◆ NeutralCVSALGNCAH

Here's How CVS' Improving Balance Sheet Supports Deleveraging

Zacks Investment Research·
Here's How CVS' Improving Balance Sheet Supports Deleveraging

CVS Health generated $10.6B in YTD operating cash flow and raised its full-year outlook to at least $11.5B, ending Q2 with $2.7B in cash. The company maintains a leverage ratio of 3.5x and expects improvement as it prioritizes balance-sheet strengthening over share buybacks in 2026-2027. Peers Align Technology and Cardinal Health also demonstrate strong liquidity positions with active capital deployment strategies.

Read Full Article at Zacks Investment Research
← Back to Financial Intelligence